Sign in

Daniel Aletaha

@danielaletaha.bsky.social
77 followers 33 following 43 posts

Rheumatologist, Medical University Vienna - Past-President of EULAR

PostsRepliesMedia
Daniel Aletaha @danielaletaha.bsky.social · 10/09/2026
Last month was particularly busy for our Division’s research, with a broad range of studies published across rheumatology and related fields. In case you missed them, here’s a recap, from biomarkers and ultrasound in rheumatoid arthritis to Sjögren disease, vaccination, and D2T RA:
111
Reposted by Daniel Aletaha
MedUni Wien @meduniwien.ac.at · 30/07/2026
💊 #Methotrexate has been the mainstay of treatment for #RheumatoidArthritis. Researchers at #MedUniVienna analysed how the drug alters the #immunesystem during the first few weeks of treatment. ⬇️ 💡 MTX triggers coordinated changes in the immune system within just a few weeks. 📰 @ard.eular.org​
meduniwien.ac.at
Rheumatoid arthritis: Early immune changes during methotrexate treatment may predict treatment success
Details of the MedUni Vienna study!
083
Daniel Aletaha @danielaletaha.bsky.social · 15/06/2026
What a fantastic #EULAR2026 in London! Proud of the outstanding scientific contributions from our Division of Rheumatology @meduniwien.ac.at, from talks, posters and chairing to leadership in key sessions. Great visibility also for @squeezeproject.bsky.social and @autopix.bsky.social!
051
Reposted by Daniel Aletaha
SQUEEZE project @squeezeproject.bsky.social · 04/06/2026
Did you notice the large crowd of people in the NPO area last night just before the networking dinner at #EULAR2026? There's heaps of passionate clinicians, scientists, HCP, & patients involved in a large number of EU consortia like SQUEEZE - come by at booth **O17** and learn more about our work!
094
Reposted by Daniel Aletaha
SQUEEZE project @squeezeproject.bsky.social · 05/06/2026
Please help us by completing this survey on the availability, accessibility & affordability of #RA treatments across Europe. The results will help identify disparities in the treatment access across Europe & support future evidence-based recommendations for more equitable care. #EULAR2026
066
Reposted by Daniel Aletaha
The European Alliance of Associations for Rheumatology @eular.org · 03/06/2026
✨ Join us at 1pm BST via livestream or in person as we officially kick off #EULAR2026! Led by the EULAR Board, the Opening Plenary brings together the community to highlight key Congress moments and honour excellence in RMDs through the Award Ceremony. Watch here 👉 pulse.ly/g91er5akam
161
Daniel Aletaha @danielaletaha.bsky.social · 03/06/2026
Safety is key in RA management! The 2025 @eular.org update, led by Faidra Laskou & Victoria Konzett, reviews DMARD risks from infections to cardiovascular events. How does this shape practice? Read more: doi.org/10.1016/j.ar.... Grateful to global collaborators for advancing RA care!
doi.org
Redirecting
010
Daniel Aletaha @danielaletaha.bsky.social · 07/05/2026
4th virtual @squeezeproject.bsky.social consortium meeting done. A moment to reflect on 3.5 years of work improving RA care and align on the road to Nov next year. Thanks to all of our partners!
031
Reposted by Daniel Aletaha
MedUni Wien @meduniwien.ac.at · 07/04/2026
Can biomarkers and personalised care end years of trial and error for people with #rheumatoidarthritis? The EU-funded SQUEEZE project, coordinated by @danielaletaha.bsky.social​ from #MedUniVienna aims to optimise existing therapies and bring more patients into remission. ⬇️ #Rheumatology
projects.research-and-innovation.ec.europa.eu
Squeezing more from arthritis drugs to help patients live better
Find out more!
162
Daniel Aletaha @danielaletaha.bsky.social · 24/03/2026
Peter Mandl reframes the synovium as a “synovial interface” where biology, imaging & patient perception intersect. His new perspective (doi.org/10.1016/j.aa...) challenges us to rethink how we assess inflammation beyond single measures and toward integrated monitoring. Congrats, Peter!
doi.org
Redirecting
000
Daniel Aletaha @danielaletaha.bsky.social · 16/03/2026
Thirty years go by quickly. Building something that lasts does not. We recently celebrated 30 years of university rheumatology in Austria. From history to AI, imaging and patient partnership, one thing is clear: the discipline is not standing still! @squeezeproject.bsky.social @autopix.bsky.social
130
Daniel Aletaha @danielaletaha.bsky.social · 19/11/2025
Today, on #MensHealthDay, let’s raise awareness of men-biased autoimmune diseases like axial spondylarthritis, and women-biased autoimmune disease in men! www.internationalmensday.info
internationalmensday.info
International Mens Day
International Men’s Day (IMD) is celebrated on 19 November every year and is marked in around 80 countries worldwide.
000
Daniel Aletaha @danielaletaha.bsky.social · 28/10/2025
Helga Lechner-Radner joined ORF’s Bewusst gesund to discuss “Leben mit Rheuma”. She highlighted that rheumatic diseases go far beyond joint pain, early diagnosis and modern therapy can truly change lives. 🎥 onepager.orf.at/bewusstgesun...
onepager.orf.at
Studiogespräch: Leben mit Rheuma
000
Daniel Aletaha @danielaletaha.bsky.social · 09/10/2025
I recently shared my thoughts on Austria’s strong global role in rheumatology in my recent Schmerz Nachrichten interview, from @eular.org initiatives to digital innovation and equity in care. Grateful to all who make this collaboration possible. 🇦🇹 link.springer.com/article/10.1...
link.springer.com
Österreichs starker Footprint in der globalen Rheuma-Community - Schmerz Nachrichten
Schmerz Nachrichten -
020
Daniel Aletaha @danielaletaha.bsky.social · 19/09/2025
At the Dresden Symposium on Autoantibodies 2025, Daniela Sieghart presented on biomarkers for RA treatment response, highlighting EU projects @squeezeproject.bsky.social & @autopix.bsky.social. Our division drives precision medicine forward, tailoring care through innovative biomarkers.
074
Daniel Aletaha @danielaletaha.bsky.social · 16/09/2025
New in Journal of Autoimmunity: our study on FAPI PET/CT in myositis-related ILD, led by Kastriot Kastrati & Peter Mandl. Findings show FAPI uptake predicts progression better than standard tools, promising step for personalized care. 📖 doi.org/10.1016/j.ja...
doi.org
Redirecting
000
Reposted by Daniel Aletaha
AutoPiX project @autopix.bsky.social · 09/09/2025
🚀 Meet our supportive partner: @inmusc.bsky.social  #InMusc is a Spanish consultancy that helps transform ideas into impact through research and #methodology training. Their mission is to make research collaborations agile, relevant, and meaningful.
172
Daniel Aletaha @danielaletaha.bsky.social · 08/09/2025
📢 New from our Division of Rheumatology: Peter Mandl on the expanding role of ultrasound in rheumatology - beyond joints to glands, vessels, lungs & muscles. Real-time, radiation-free imaging for diagnosis & management. 🎥 www.youtube.com/watch?v=XgOO...
000
Daniel Aletaha @danielaletaha.bsky.social · 01/09/2025
Our study on how global recruitment patterns affect placebo response in RA trials has gained broad Austrian media coverage (ORF, NÖN, SN & more). Great to see interest in how trial design impacts fair evaluation of new therapies! 🔗 science.orf.at/stories/3231...
science.orf.at
Stärkerer Placeboeffekt bei Ärmeren
Der Placeboeffekt und die sozioökonomische Lebensrealität hängen laut Untersuchungen der Wiener MedUni zusammen. In Studien aus ärmeren Ländern reagieren die Probanden und Probandinnen stärker auf das...
000
Daniel Aletaha @danielaletaha.bsky.social · 25/08/2025
Two new papers from our division show that recruiting RA & PsA trial patients in less affluent regions increase placebo rates - likely from limited treatment access. Trial design must adapt. RA: doi.org/10.1016/j.ar... PsA: doi.org/10.1002/art....
doi.org
Redirecting
000
Reposted by Daniel Aletaha
The European Alliance of Associations for Rheumatology @eular.org · 21/08/2025
Join the 9th EULAR Course on Immunology 2026, a highly interactive course focused on key immunology concepts and practical research project design. 📅 6-7 February 2026 📍Amsterdam, Netherlands 🔔Registration deadline: 2 November 2025 Register here: pulse.ly/nul3x4sazs #eularEDUCATION
021
Daniel Aletaha @danielaletaha.bsky.social · 18/08/2025
Can we collect meaningful patient-reported outcomes in rheumatology using a smartphone app? 📱 Our latest study says YES. Check it out in RMD Open: 👉 doi.org/10.1136/rmdo...
doi.org
Collecting patient-reported outcomes via the COTIDIANA smartphone app: a prospective validity study
Background Self-management of rheumatic and musculoskeletal diseases often involves regular assessments of disease-related outcomes. In recent years, smartphone apps are used to collect electronic pat...
000
Reposted by Daniel Aletaha
European Medical Journal @emjreviews.com · 18/08/2025
‪Discover more of @danielaletaha.bsky.social‬, @meduniwien.ac.at and past ‪@eular.org‬ president's thoughts on EMJ: www.emjreviews.com/rheumatology...
011
Reposted by Daniel Aletaha
The European Alliance of Associations for Rheumatology @eular.org · 12/08/2025
Join the 8th EULAR Imaging Course 2026, an intensive, hands-on course covering key imaging techniques in rheumatology, from X-ray to MRI and ultrasound. 📅5-6 February 2026 📍Amsterdam, Netherlands 🔔Registration deadline: 2 November 2025 Register here: pulse.ly/5a9ni8gnzs #eularEDUCATION
011
Reposted by Daniel Aletaha
The European Alliance of Associations for Rheumatology @eular.org · 01/08/2025
📸 Behind every project is a team. During the EULAR 2025 Congress in Barcelona, we had the pleasure to meet with members of six research consortia: HIPPOCRATES, SQUEEZE, STRATA-FIT, MDR-RA, PerPrev-CID, and AutoPiX. 👉 Interested in partnering with us? Learn more here: pulse.ly/58wj8jwuui
082
Reposted by Daniel Aletaha
The European Alliance of Associations for Rheumatology @eular.org · 06/08/2025
🚀Join us on our #EULAR and #EMEUNET Webinar: "Gender-specific differences in rheumatic diseases" 💻Wednesday, 13 Aug 2025, 18:00-18:45 CEST Register here👉https://pulse.ly/lqp4vkeeod #eularEMEUNET #Rheumatology
041
Daniel Aletaha @danielaletaha.bsky.social · 07/08/2025
Can women with systemic autoimmune rheumatic diseases pass on robust immunity to their babies? Turns out - yes. 👶🛡️ Proud to share our latest collaborative study on maternal antibody transfer in the Journal of Autoimmunity: doi.org/10.1016/j.ja...
doi.org
Redirecting
020
Daniel Aletaha @danielaletaha.bsky.social · 01/08/2025
At KinderUni 2025, our division of Rheumatology @meduniwien.ac.at explored the fascinating world of autoimmunity with Vienna’s youngest scientists. Huge thanks to our amazing team for inspiring future researchers! 👉 kinderuni-anmeldung.at/event.php?ev...
040
Reposted by Daniel Aletaha
MedUni Wien @meduniwien.ac.at · 10/07/2025
Idiopathic #inflammatorymyopathies are rare #autoimmunediseases in which the #immunesystem attacks the body's own #musclecells. A team from #MedUniVienna has systematically described the safety and efficacy of targeted #immunotherapy in refractory idiopathic inflammatory #myopathies. ⬇️
meduniwien.ac.at
New treatment option investigated for difficult-to-treat muscle inflammation
Details on the results of the retrospective observational study!
143
Daniel Aletaha @danielaletaha.bsky.social · 07/07/2025
New review in Joint Bone Spine co-authored by our team highlights ultrasound's expanding role from joints to organ involvement in rheumatic diseases. Read more 👉 www.sciencedirect.com/science/arti...
sciencedirect.com
Ultrasound in rheumatic and musculoskeletal diseases: From musculoskeletal to organ involvement
In last two decades, the use of ultrasound has assumed an increasingly important role in the assessment of almost all rheumatic and musculoskeletal di…
010
Daniel Aletaha @danielaletaha.bsky.social · 30/06/2025
Great meeting in Stockholm with the @autopix.bsky.social team! Thanks @collectiveminds.bsky.social for hosting. We're advancing AI tools to improve rheumatic care - excited for what’s ahead!
020
Daniel Aletaha @danielaletaha.bsky.social · 26/06/2025
Check out the interview I made within the frame of #EULAR2025 with the talented EMEUNET Newsletter Sub-Committee members Anastasia Madenidou and Victoria Konzett 👇 emeunews.org/2025/06/01/t...
010
Daniel Aletaha @danielaletaha.bsky.social · 13/06/2025
Check out my interview, masterfully led by Valentina Pucino after the plenary session of #EULAR2025 👇 www.youtube.com/watch?v=d6hi...
youtube.com
EULAR 2025 - Interview with Prof. Daniel Aletaha
YouTube video by EULAR
083
Daniel Aletaha @danielaletaha.bsky.social · 12/06/2025
Proud to showcase the @squeezeproject.bsky.social at #EULAR2025! Visit booth O9 (near Hall 8.1, NPO area) to learn how we’re advancing precision medicine in RA to get the right treatment to the right patient.
030
Daniel Aletaha @danielaletaha.bsky.social · 12/06/2025
Proud of our @autopix.bsky.social at #EULAR2025! Visit us at booth O8 (near Hall 8.1, NPO area) to learn how we’re using AI to advance rheumatic image analysis for better patient care.
050
Reposted by Daniel Aletaha
Lupus Europe @lupuseurope.bsky.social · 11/06/2025
And that’s the start of what it’s going to be a very exciting @eular.org Congress! Open ceremony with @danielaletaha.bsky.social #EULAR2025
031
Reposted by Daniel Aletaha
SQUEEZE project @squeezeproject.bsky.social · 02/06/2025
🎙️ Mark the first of many SQUEEZE talks at #EULAR2025: "Add-on vs. Replacement csDMARDs post-MTX. A European analysis on csDMARD Treatment Choices." Presented by Nils Steinz from Leiden University Medical Center (LUMC) on June 12, at 10:50 am at room A2. #RA #DMARD #PrecisionMedicine
073
Daniel Aletaha @danielaletaha.bsky.social · 28/05/2025
🟣 Today, on International Day of Action for Women’s Health, we reaffirm: women’s health is central to rheumatology - from research to care. Let’s keep pushing forward. may28.org #WomensHealthMatters #Rheumatology #AutoimmuneDiseases #HealthEquity
may28.org
May 28 – International Day of Action for Women's Health
042
Daniel Aletaha @danielaletaha.bsky.social · 26/05/2025
I was interviewed by my team to share why EULAR 2025 in Barcelona will be exciting—and why you shouldn't miss it!📺 www.youtube.com/watch?v=rvf5... #EULAR2025
youtube.com
Prof. Daniel Aletaha on the upcoming EULAR 2025 Congress (#1)
YouTube video by Division of Rheumatology - MUW Vienna
010
Daniel Aletaha @danielaletaha.bsky.social · 22/05/2025
Can we prevent rheumatoid arthritis before it starts? Research on preclinical RA suggests early intervention could halt or delay the disease. Could prevention be the future of RA care? Read our latest editorial! 🔗 doi.org/10.1016/j.jb...
doi.org
Redirecting
000
Daniel Aletaha @danielaletaha.bsky.social · 15/05/2025
Last week was our first meetup with the Patient Research Partners involved in our IHI-funded AutoPiX project! We’re using AI to dig deeper into imaging data in rheumatic diseases care. Big thanks to everyone bringing their voice to the table! 💬🤝 #PatientInvolvement #Rheumatology #AI
011
Daniel Aletaha @danielaletaha.bsky.social · 24/04/2025
Proud to share that Josef S. Smolen has been named a 2024 Highly Ranked Scholar – Lifetime by ScholarGPS, placing him in the top 0.05% worldwide in medicine (tinyurl.com/3kwv6wem). A true inspiration and mentor — congratulations, Josef, particularly from all your academic offspring! 👏
tinyurl.com
020
Daniel Aletaha @danielaletaha.bsky.social · 22/04/2025
🎧 New on the Digital Rheumatology Network podcast: Our very own Paul Studenic shares his insights from ACR & EULAR, tech trends, and patient empowerment: 🔗 tinyurl.com/3j8ha8ch #DigitalRheumatology #DigitalHealth #EULAR #ACR #FutureOfCare
tinyurl.com
Insights: 7th DRD - Paul Studenic
Digital Rheumatology Network · Episode
020
Daniel Aletaha @danielaletaha.bsky.social · 17/04/2025
🎉 Halfway there! Our @SQUEEZE project hits its 2.5-year mark! We've advanced RA treatment with biomarker research, launched 3 clinical trials, and strengthened patient engagement. Exciting progress ahead as we optimize therapies! Stay tuned: tinyurl.com/47uv45ts
tinyurl.com
SQUEEZE | LinkedIn
SQUEEZE | 462 followers on LinkedIn. Let's squeeze the best out of existing treatments in #rheumatoid #arthritis | Rheumatoid arthritis (RA) is a chronic autoimmune disease, which has an enormous ...
030
Daniel Aletaha @danielaletaha.bsky.social · 14/04/2025
Josef Smolen and I co-founded Preferrix to improve clinical trial access. Now live as a Meduniwien spin-off, it connects doctors and trial centers, expanding recruitment beyond specialized clinics and for all patients regardless of where they receive care: tinyurl.com/34659wwc
tinyurl.com
MedUni Vienna physicians develop tool to enhance trial access
MedUni Vienna physicians Daniel Aletaha and Josef Smolen have developed the Preferrix digital tool to enhance clinical trial access.
020
Daniel Aletaha @danielaletaha.bsky.social · 10/04/2025
How should we treat undifferentiated arthritis in 2025? Annette van der Helm-van Mil and I challenge existing paradigms a recent viewpoint. UA is not just "early RA"—today’s patients present differently, with milder disease and frequent remission. Time to rethink treatment. doi.org/10.1016/j.ar...
doi.org
Redirecting
000
Daniel Aletaha @danielaletaha.bsky.social · 03/04/2025
Check out our new reviews on JAK inhibitors in IMIDs: 📌 Efficacy: 102 RCTs, 21 JAK inhibitors, 51 diseases—strong evidence across IMIDs. 📌 Safety: 209 studies analyzed risks like CV events, infections, malignancies. doi.org/10.1016/j.ar... & doi.org/10.1016/j.ar...
doi.org
Redirecting
010
Daniel Aletaha @danielaletaha.bsky.social · 27/02/2025
Ich freue mich, mein Interview mit Die ganze WOCHE zu teilen: tinyurl.com/bdzz8ss8 📰 Wie uns künstliche Intelligenz hilft die Behandlung von entzündlichem Gelenksrheuma präziser zu gestalten und wie wir in unserem AutoPiX-Projekt die Auswertung von Bilddaten verbessern: www.autopix-project.eu 🏥🔬
tinyurl.com
Die ganze WOCHE: Artikel
021
Daniel Aletaha @danielaletaha.bsky.social · 30/01/2025
Our Division of Rheumatology hosted its annual General Recess—an inspiring forum for research exchange! This year, we also launched Rheumavation, a 1-minute pitch challenge for innovative ideas. Congrats to our first-ever winners, Marlene Steiner & Lisabeth Emilius! 👏 #Rheumatology #Innovation
020